IRIS
BENNETT, DAVID
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.690
NA - Nord America 4.099
AS - Asia 737
AF - Africa 29
OC - Oceania 11
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.575
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.071
IT - Italia 1.794
GB - Regno Unito 1.219
IE - Irlanda 919
RU - Federazione Russa 386
CN - Cina 363
SE - Svezia 362
DE - Germania 263
UA - Ucraina 221
FR - Francia 215
SG - Singapore 184
FI - Finlandia 142
VN - Vietnam 51
ES - Italia 48
IN - India 44
CZ - Repubblica Ceca 39
TR - Turchia 31
CA - Canada 26
CI - Costa d'Avorio 25
HK - Hong Kong 21
BE - Belgio 18
PL - Polonia 13
AU - Australia 10
IR - Iran 10
NL - Olanda 8
MK - Macedonia 7
PH - Filippine 7
CH - Svizzera 5
PT - Portogallo 5
DK - Danimarca 4
GR - Grecia 4
ID - Indonesia 4
KZ - Kazakistan 4
AZ - Azerbaigian 3
EU - Europa 3
JP - Giappone 3
KG - Kirghizistan 3
LK - Sri Lanka 3
RO - Romania 3
EC - Ecuador 2
IL - Israele 2
LV - Lettonia 2
MA - Marocco 2
MX - Messico 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
BO - Bolivia 1
BR - Brasile 1
BY - Bielorussia 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 10.575
Salva come PNG Salva come JPEG
Città #
Southend 1.119
Dublin 903
Fairfield 586
Chandler 451
Ashburn 340
Siena 279
Woodbridge 256
Seattle 209
Wilmington 208
Ann Arbor 202
Cambridge 184
Jacksonville 178
Houston 166
Singapore 159
Princeton 122
Helsinki 104
Florence 101
New York 95
Milan 87
Beijing 86
Munich 60
Boardman 56
Dearborn 54
Nanjing 52
Dong Ket 50
Rome 49
Fremont 44
Moscow 43
Málaga 43
Shanghai 41
London 40
San Mateo 37
Catania 32
San Diego 27
Menlo Park 26
Abidjan 25
Brno 24
Izmir 24
Nanchang 20
Washington 19
Brussels 18
Lastra a Signa 18
Los Angeles 18
Shenyang 18
Gavirate 17
Nuremberg 16
Padova 16
Chicago 15
Guangzhou 14
Hebei 14
Norwalk 14
Olomouc 13
Trieste 13
Hong Kong 12
San Francisco 12
Arezzo 11
Jiaxing 11
Paris 11
Changsha 10
Comun Nuovo 10
Figline Valdarno 10
Redwood City 10
Toronto 10
Dallas 9
Düsseldorf 9
Frankfurt am Main 9
Kunming 9
Miami 9
Montecatini Terme 9
Naples 9
Napoli 9
Prato 9
Tianjin 9
Venezia 9
Zhengzhou 9
Cagliari 8
Bergamo 7
Catanzaro 7
Como 7
Genoa 7
Livorno 7
Santa Clara 7
Sesto Fiorentino 7
Aachen 6
Anagni 6
Bologna 6
Clifton 6
Empoli 6
Espoo 6
Hyderabad 6
Jinan 6
Lancaster 6
Mumbai 6
Ningbo 6
Perugia 6
Pisa 6
Ponte Buggianese 6
Rubano 6
Verona 6
Warsaw 6
Totale 7.179
Salva come PNG Salva come JPEG
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 958
Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis 308
Antirheumatic agents in covid-19: is IL-6 the right target? 198
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers 194
Peripheral biomarkers' panel for severe COVID-19 patients 192
Exhaled nitric oxide in interstitial lung diseases 188
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 188
Idiopathic pulmonary fibrosis a rare disease with severe bone fragility 185
Posttransplant solid organ malignancies in lung transplant recipients: A single-center experience and review of the literature 183
Diagnosis of idiopathic pulmonary fibrosis by virtual means using “IPFdatabase”- a new software 181
Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns 180
Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis 176
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 174
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 166
null 165
Rituximab Therapy in Interstitial Lung Disease associated with Rheumatoid Arthritis 163
Serum chitotriosidase levels in patients with allergic and non-allergic asthma 158
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 155
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 152
Pirfenidone therapy for familial pulmonary fibrosis: a real-life study. 150
Diffuse panbronchiolitis in a patient with common variable immunodeficiency: a casual association or a pathogenetic correlation? 149
Bronchial stenosis following lung transplant: An innovative approach with a modified endobronchial emphysema valve 148
null 145
Oxidative stress in the pathogenesis of diffuse lung diseases: a review 142
Airway-Centered Pleuroparenchymal Fibroelastosis Associated with Non-Necrotizing Granulomas: A Rare New Entity 142
Prognostic bioindicators in severe COVID-19 patients 139
Serum amyloid A in patients with idiopathic pulmonary fibrosis 137
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 137
Extracorporeal Photopheresis in Lung Transplantation 136
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 130
Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis 128
Proteomic investigation of pulmonary sarcoidosis 127
Biomarkers in sarcoidosis: The contribution of system biology 127
Human Chitotriosidase: a sensitive biomarker of sarcoidosis 125
Serial KL-6 measurements in COVID-19 patients 125
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 124
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study 123
SARS-CoV-2 in pleural fluid in a kidney transplant patient 123
null 121
Pirfenidone in chronic lung allograft dysfunction: a single cohort study 118
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 118
New concepts in the pathogenesis of sarcoidosis 117
IPF mortality in waiting list for lung transplantation 116
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 116
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 114
A first update on mapping the human genetic architecture of COVID-19 112
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 107
Timing of Osteoporotic Vertebral Fractures in Lung and Heart Transplantation: A Longitudinal Study 107
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 107
null 106
Valutazione dell'ossido nitrico nell'esalato delle polmoniti interstiziali idiopatiche 104
An explainable model of host genetic interactions linked to COVID-19 severity 103
Helicobacter pylori antibody positivity in idiopathic pulmonary fibrosis 103
Mortalità in lista per trapianto di polmone in pazienti affetti da fibrosi polmonare idiopatica 103
Chitotriosidase: a sensitive biomarker of sarcoidosis 102
BIOMARKERS WITH CLINICAL SIGNIFICANCE IN PATIENTS WITH INTERSTITIAL LUNG DISEASES 99
WES profiling of COVID-19 96
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 92
Impact of SARS-CoV-2 outbreak on heart and lung transplant: a patient-perspective survey 92
Outcome of ECMO bridge to lung transplantation: a single cohort study 91
Familial pulmonary fibrosis: Clinical-functional and radiological features 88
IPFdatabase - A new tool for a correct application of idiopathic pulmonaty fibrosis guidelines 87
Pulse oximetry oxyhemoglobin saturation in patients with idiopathic pulmonary fibrosis 86
Rischio infettivo nel trapianto di polmone per fibrosi polmonare: analisi retrospettiva 86
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 86
Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution 81
The Role of Galectins in Chronic Lung Allograft Dysfunction 67
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 64
Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent 63
Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosis 59
Incidenza e fattori di rischio per colonizzazione ed infezione respiratoria batterica a 30 giorni in pazienti trapiantati di polmone 56
Exhaled nitric oxide and carbon monoxide in lung transplanted patients 55
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review 55
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients 55
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 53
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 48
Cavernous sinus syndrome due to neurosarcoidosis in adolescence: a diagnosis not to be missed 46
Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence 45
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction 42
Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective 42
Relapses of idiopathic inflammatory myopathies after vaccination against COVID19: a real-life Italian study 41
Whole-genome sequencing reveals host factors underlying critical COVID-19 40
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 39
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases 37
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study 37
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 37
Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant 35
NK and T cell in patients with end-stage lung disorders waiting for lung transplantation in response to CMV infection 34
NK and T cells responses to CMV in patients awaiting for lung transplantation 31
Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP 25
Calgranulin B/S100A9 and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP 24
Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity 22
Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience 20
Lung transplantation in patients with previous or unknown oncological disease: evaluation of short- and long-term outcomes 12
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 12
Erratum: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis (Respiratory Research (2020) 21 (6) DOI: 10.1186/s12931-019-1263-z) 12
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 5
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 3
Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases 3
Totale 10.898
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.473
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020968 0 0 0 0 83 134 130 171 125 133 72 120
2020/20211.660 56 118 43 197 190 194 104 201 144 151 137 125
2021/20221.271 103 153 89 101 73 48 58 73 51 120 152 250
2022/20231.826 149 189 201 228 153 270 157 153 157 76 57 36
2023/20241.782 76 49 186 90 82 416 542 68 16 48 51 158
2024/2025965 125 167 432 173 68 0 0 0 0 0 0 0
Totale 10.898